Authors: Piro, LD White, CA Grillo-Lopez, AJ Janakiraman, N Saven, A Beck, TM Varns, C Shuey, S Czuczman, M Lynch, JW Kolitz, JE Jain, V

Citation: Ld. Piro et al., Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed orrefractory low-grade or follicular non-Hodgkin's lymphoma, ANN ONCOL, 10(6), 1999, pp. 655-661

Authors: Czuczman, MS Grillo-Lopez, AJ White, CA Saleh, M Gordon, L LoBuglio, AF Jonas, C Klippenstein, D Dallaire, B Varns, C

Citation: Ms. Czuczman et al., Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy, J CL ONCOL, 17(1), 1999, pp. 268-276

Authors: Dallaire, BK Deardorff, JA White, CA Dowden, S Varns, C Shen, D Grillo-Lopez, AJ

Citation: Bk. Dallaire et al., Antibody therapy with Rituximab for patients with low-grade non-Hodgkin's lymphoma, ONKOLOGIE, 22(3), 1999, pp. 184-190

Authors: Grillo-Lopez, AJ White, CA Varns, C Shen, D Wei, A McClure, A Dallaire, BK

Citation: Aj. Grillo-lopez et al., Overview of the clinical development of rituximab: First monoclonal antibody approved for the treatment of lymphoma, SEMIN ONCOL, 26(5), 1999, pp. 66-73